Alector (ALEC) Depreciation & Amortization (CF) (2018 - 2026)
Alector's (ALEC) quarterly Depreciation & Amortization (CF) came in at $1.0 million in Q2 2026, down 54.96% year-over-year from $2.3 million in Q2 2025, and down 2.96% quarter-over-quarter from $1.1 million in Q1 2026.
Analysis
Alector (ALEC) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Depreciation & Amortization (CF) for 9 consecutive years, with $1.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Depreciation & Amortization (CF) fell 54.96% year-over-year to $1.0 million in Q2 2026; TTM through Jun 2026 was $4.5 million, a 22.78% decrease from a year earlier, with the FY2025 full-year figure at $5.7 million, up 5.75% from the prior year.
- Depreciation & Amortization (CF) was $1.0 million for Q2 2026 at Alector, down from $1.1 million in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $2.3 million in Q2 2025 and troughed at $984000.0 in Q1 2025.
- A 5-year average of $1.4 million and a median of $1.4 million in 2022 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) surged 65.88% in 2025 and plunged 54.96% in 2026, its largest moves.
- Over 5 years, Depreciation & Amortization (CF) stood at $1.4 million in 2022, then climbed by 3.08% to $1.4 million in 2023, then fell by 13.57% to $1.2 million in 2024, then slipped by 5.96% to $1.2 million in 2025, then decreased by 10.19% to $1.0 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $1.0 million (Q2 2026), $1.1 million (Q1 2026), and $1.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 1.11 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 56.50 Mn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 123.70 Mn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | - |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 236.10 Mn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | - |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - | 1.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.05 Mn |
| Mar 31, 2026 | 1.08 Mn |
| Dec 31, 2025 | 1.17 Mn |
| Sep 30, 2025 | 1.24 Mn |
| Jun 30, 2025 | 2.33 Mn |
| Mar 31, 2025 | 984,000.00 |
| Dec 31, 2024 | 1.24 Mn |
| Sep 30, 2024 | 1.32 Mn |
| Jun 30, 2024 | 1.40 Mn |
| Mar 31, 2024 | 1.44 Mn |
| Dec 31, 2023 | 1.44 Mn |
| Sep 30, 2023 | 1.46 Mn |
| Jun 30, 2023 | 1.46 Mn |
| Mar 31, 2023 | 1.36 Mn |
| Dec 31, 2022 | 1.39 Mn |
| Sep 30, 2022 | 1.35 Mn |
| Jun 30, 2022 | 1.38 Mn |
| Mar 31, 2022 | 1.59 Mn |
| Dec 31, 2021 | 1.59 Mn |
| Sep 30, 2021 | 1.61 Mn |